ArticleFrontiers in fungal biology2026
Synthesis, characterization, and antifungal activity of chitosan-copper nanocomposites against crop pathogens.
Article in Frontiers in fungal biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nano-Enabled Precision Management of Plant Anthracnose: Mechanisms of Action, Application Advances, and Future Perspectives.Journal of fungi (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chitosan-copper nanoparticles (CHT-Cu NPs) were synthesized using an ionic gelation approach and evaluated for their physicochemical properties and antifungal activity against major fungal pathogens of chickpea and citrus. For instance, "In recent years, nanotechnology-based formulations have emerged as promising strategy for sustainable disease management". Dynamic light scattering analysis revealed uniformly sized nanoparticles (~150 nm) with low polydispersity and a positive surface charge (+22.2 mV). Fourier transform infrared spectroscopy, X-ray diffraction, scanning and transmission electron microscopy, and energy-dispersive X-ray analysis confirmed effective copper coordination, amorphous nanocomposite formation, and stable incorporation of copper within the chitosan matrix. The antifungal efficacy of CHT-Cu NPs was assessed
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.